Gorgani, Nick N, Karl H. S. Kim, Wendy L. Free, Mahnoosh Afkham, Jeremy D. Henson, Paramesh Shamanna, Shahnam Ajdari, C. Ronald Kahn, Timothy R. Hirst, Anthony H. Barnett, and Sanjoy K. Paul. 2022. “OZ101, an Oligofructose Prebiotic, May Prolong Sulphonylurea Efficcy in Patients With Type 2 Diabetes: A Pilot Study: OZ101 and Sulphonylurea-Mediated Glycaemic Control”. Journal of Current Medical Research and Opinion 5 (06):1235-51. https://doi.org/10.52845/CMRO/2022/5-6-2.